Statements (20)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
phosphate binder |
gptkbp:approvedBy |
gptkb:FDA
2013 |
gptkbp:ATCCode |
gptkb:V03AE05
|
gptkbp:brand |
gptkb:Velphoro
|
gptkbp:chemicalFormula |
FeO(OH)·sucrose
|
gptkbp:developedBy |
gptkb:Vifor_Pharma
|
gptkbp:eliminatedIn |
fecal
|
https://www.w3.org/2000/01/rdf-schema#label |
sucroferric oxyhydroxide
|
gptkbp:legalStatus |
prescription only
|
gptkbp:mechanismOfAction |
binds dietary phosphate in the gut
|
gptkbp:pregnancyCategory |
C (US)
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
nausea
diarrhea discolored feces |
gptkbp:usedFor |
hyperphosphatemia in chronic kidney disease
|
gptkbp:bfsParent |
gptkb:Velphoro
|
gptkbp:bfsLayer |
8
|